Abbott Laboratories to avail more rapid COVID-19 test kits by end October

USA – Abbott Laboratories has announced that its rapid test device, BinaxNOW COVID-19 antigen Card, will be widely available again by the end of October. The FDA had granted emergency use authorization (EUA) to Abbott’s widely used BinaxNOW rapid test for use at home with a prescription via a virtually guided online service. Because of its small size can be used in less traditional settings where people can get results in minutes, bringing an alternate testing technology to combat the novel coronavirus. The BinaxNOW COVID-19 Ag Card can be used…

Read More

Organ transplant milestone as Thermo Fisher launches robust diagnostic technologies

USA – Thermo Fisher Scientific has announced two new additions to its transplant diagnostics portfolio at the annual meeting for the American Society for Histocompatibility and Immunogenetics (ASHI). These new products will allow transplant laboratories to better characterize samples while also increasing speed and confidence. The transplant diagnostics market comprises of the sale of transplant diagnostics test products as well as related services. Transplant diagnostics are tests performed prior to the relocation or transplantation of a donor organ to a recipient patient. Human leukocyte antigen (HLA) diagnostic testing, PCR-based assay,…

Read More